REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $479,268 | -44.5% | 40,955 | -0.0% | 0.00% | -66.7% |
| Q1 2024 | $863,259 | +17.2% | 40,971 | -0.2% | 0.00% | +50.0% |
| Q4 2023 | $736,883 | +9.5% | 41,052 | +0.4% | 0.00% | -33.3% |
| Q3 2023 | $673,165 | -17.7% | 40,897 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $817,531 | +105660.8% | 40,897 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $773 | +15360.0% | 40,897 | +17303.0% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 235 | -56.1% | 0.00% | – |
| Q3 2022 | $14,000 | -41.7% | 535 | -45.7% | 0.00% | – |
| Q2 2022 | $24,000 | 0.0% | 985 | +34.0% | 0.00% | – |
| Q1 2022 | $24,000 | 0.0% | 735 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -20.0% | 735 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | +7.1% | 735 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | +12.0% | 735 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +13.6% | 735 | +47.0% | 0.00% | – |
| Q4 2020 | $22,000 | +69.2% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | +116.7% | 500 | +400.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |